TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 South & Central America T Cell Therapy Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America T Cell Therapy Market - Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Growing Burden of Cancer Worldwide
4.1.2 Increasing Number of T-Cell Therapy Approvals
4.2 Market Restraints
4.2.1 Side-effects of CAR T-Cell Therapy
4.3 Market Opportunities
4.3.1 Growing Investment in T-Cell Therapy
4.4 Future Trends
4.4.1 Rising Number of CAR T-Cell Therapies in Clinical Trials
4.5 Impact Analysis:
5. T Cell Therapy Market - South & Central America Market Analysis
5.1 South & Central America T Cell Therapy Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 - by Modality.
6.1 Overview
6.2 South & Central America T Cell Therapy Market Revenue Share, by Modality, 2022 & 2030 (%)
6.3 Research
6.3.1 Overview
6.3.2 Research: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Commercialized
6.4.1 Overview
6.4.2 Commercialized: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 - by Therapy Type
7.1 Overview
7.2 South & Central America T Cell Therapy Market Revenue Share, by Therapy Type 2022 & 2030 (%)
7.3 CAR T-cell Therapy
7.3.1 Overview
7.3.2 CAR T-cell Therapy: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 T-cell Receptor (TCR)-based.
7.4.1 Overview
7.4.2 T-cell Receptor (TCR)-based: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 - by Indication
8.1 Overview
8.2 South & Central America T Cell Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
8.3 Hematologic Malignancies
8.3.1 Overview
8.3.2 Hematologic Malignancies: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3.3 South & Central America T Cell Therapy Market , by Haematological Malignancies, 2020-2030 (US$ Million)
8.4 Solid Tumor
8.4.1 Overview
8.4.2 Solid Tumor: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America T Cell Therapy Market - Country Analysis
9.1 Overview
9.1.1 South & Central America T Cell Therapy Market by Country
9.1.1.1 Brazil
9.1.1.1.1 Brazil: South & Central America T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.1.2 Brazil: South & Central America T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.1.3 Brazil: South & Central America T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.1.4 Brazil: South & Central America T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.1.4.1 Brazil: South & Central America T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
10. T Cell Therapy Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in T Cell Therapy Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Janssen Global Services LLC
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Gilead Sciences Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Bristol-Myers Squibb Co
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Novartis AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms



List of Tables
Table 1. South & Central America T Cell Therapy Market Segmentation 8
Table 2. South & Central America T Cell Therapy Market , by Hematological Malignancies - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: South & Central America T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: South & Central America T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: South & Central America T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 7. Recent Organic Growth Strategies in South & Central America T Cell Therapy Market
Table 8. Recent Inorganic Growth Strategies in the South & Central America T Cell Therapy Market
Table 9. Glossary of Terms, South & Central America T Cell Therapy Market

List of Figures
Figure 1. South & Central America T Cell Therapy Market Segmentation, By Country 9
Figure 2. South & Central America T Cell Therapy Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America T Cell Therapy Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America T Cell Therapy Market Revenue Share, by Modality, 2022 & 2030 (%)
Figure 6. Research: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Commercialized: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. South & Central America T Cell Therapy Market Revenue Share, by Therapy Type 2022 & 2030 (%)
Figure 9. CAR T-cell Therapy: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. T-cell Receptor (TCR)-based: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. South & Central America T Cell Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
Figure 12. Hematologic Malignancies: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Solid Tumor: South & Central America T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America T Cell Therapy Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 15. South & Central America T Cell Therapy Market , By Key Countries, 2022 and 2030 (%)
Figure 16. Brazil: South & Central America T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 17. Growth Strategies in T Cell Therapy Market



CONTACT US

If you have any queries about this report or would like further information, please contact us:

US: +1-646-491-9876
Asia-Pacific: +91-20-69018686
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com




DISCLAIMER

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, \"The Insight Partners\".